Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Nirav Bhalani"'
Autor:
Kamal Sharma, Sameer Dani, Devang Desai, Prathap Kumar, Nirav Bhalani, Apurva Vasavada, Rutvik Trivedi
Publikováno v:
Journal of Cardiovascular and Thoracic Research, Vol 13, Iss 2, Pp 162-168 (2021)
Introduction: To evaluate the efficacy/safety profile of the Abluminus DES+ over 2-years follow-up in the "real-world" scenario in diabetics as compared to non-diabetics. Methods: In prospective, all-comers, open-label registry conducted at 31 sites,
Externí odkaz:
https://doaj.org/article/943d45a9d14f4815888892b5e4aaecd7
Autor:
Anuja Pandit, Nirav Bhalani, B.L. Shashi Bhushan, Parshottam Koradia, Shweta Gargiya, Vinay Bhomia, Kevinkumar Kansagra
Publikováno v:
International Journal of Infectious Diseases, Vol 105, Iss , Pp 516-521 (2021)
Objective: To evaluate the efficacy and safety of pegylated interferon alfa-2b (PEG IFN-α2b) along with the standard of care (SOC) in subjects with moderate COVID-19. Methods: In this phase 2, randomized, open-label study, adult subjects aged ≥18
Externí odkaz:
https://doaj.org/article/db1045fd9fbc4939a9d4129a5d9bf40c
Autor:
Anuja Pandit, Nirav Bhalani, B.L. Shashi Bhushan, Parshottam Koradia, Shweta Gargiya, Vinay Bhomia, Kevinkumar Kansagra
Publikováno v:
International Journal of Infectious Diseases, Vol 109, Iss , Pp 322- (2021)
Externí odkaz:
https://doaj.org/article/a241828a658d44b9a2af2cd2625831a8
Autor:
Rashmit Pandya, Antonio Popolo Rubbio, Matteo Casenghi, Arvind Sharma, Pritesh Parekh, Sameer Dani, Devang Desai, Chirag Seth, Luca Testa, F. Bedogni, Nirav Bhalani
Publikováno v:
Minerva cardiology and angiology. 69(5)
BACKGROUND Patients with diabetes mellitus (DM) represents a challenging subset of population as they experience worse outcomes after percutaneous coronary intervention than patients without diabetes. We evaluated the 2-year efficacy and safety profi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::083bd38b73941eb506e45f6cff02571c
https://pubmed.ncbi.nlm.nih.gov/33823572
https://pubmed.ncbi.nlm.nih.gov/33823572
Autor:
Nirav Bhalani, Anuja Pandit, Parshottam Koradia, Vinay Bhomia, Kevinkumar Kansagra, B.L. Shashi Bhushan, Shweta Gargiya
Publikováno v:
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 105, Iss, Pp 516-521 (2021)
International Journal of Infectious Diseases, Vol 105, Iss, Pp 516-521 (2021)
Objective: To evaluate the efficacy and safety of pegylated interferon alfa-2b (PEG IFN-α2b) along with the standard of care (SOC) in subjects with moderate COVID-19. Methods: In this phase 2, randomized, open-label study, adult subjects aged ≥18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::144cfe4c1e33e7c1ecdf3099cf686acb
http://europepmc.org/articles/PMC7944859
http://europepmc.org/articles/PMC7944859
Autor:
Nirav Bhalani, Kevinkumar Kansagra, Anuja Pandit, Parshottam Koradia, Vinay Bhomia, Shweta Gargiya, B.L. Shashi Bhushan
Publikováno v:
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 109, Iss, Pp 322-(2021)
International Journal of Infectious Diseases, Vol 109, Iss, Pp 322-(2021)
To evaluate the efficacy and safety of pegylated interferon alfa-2b (PEG IFN-α2b) along with the standard of care (SOC) in subjects with moderate COVID-19.In this phase 2, randomized, open-label study, adult subjects aged ≥18 years with RT-PCR con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9473d49c8d61f01d2a96b28b0b93047
https://doi.org/10.1016/j.ijid.2021.06.030
https://doi.org/10.1016/j.ijid.2021.06.030
Autor:
Nirav Bhalani, Chirag Seth, Francesco Bedogni, Poonam Chodvadiya, Mainish Doshi, Prakash Sojitra, Arvind Sharma, Pritesh Parekh, Luca Testa, Sameer Dani, Gopee Dutta, Dewang Desai, Rashmit Pandya
Publikováno v:
Minerva cardioangiologica. 66(5)
Background Patients with diabetes mellitus (DM) have poorer outcomes after percutaneous coronary intervention than patients without diabetes. The Abluminus DES+™ drug-eluting stent (DES) features a novel technology of fusion coating of PLLA bioreso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf77ff016ee787179997833939736e9c
https://pubmed.ncbi.nlm.nih.gov/29687699
https://pubmed.ncbi.nlm.nih.gov/29687699
Autor:
Dinesh Shah, Rashmit Pandya, Apurva Vasavada, Devang Desai, Sameer Dani, Pritesh Parekh, Nirav Bhalani, Luca Testa, Chirag C. Sheth
Publikováno v:
Journal of the American College of Cardiology. 74:B615
Patients with diabetes mellitus (DM) have poorer outcomes after percutaneous coronary intervention than those without diabetes. We evaluate the 2-year safety and efficacy profile of the Abluminus DES+ in patients with diabetes within the population e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17a5617b07de14bca137c26b7e410935
https://doi.org/10.1016/j.jacc.2019.08.744
https://doi.org/10.1016/j.jacc.2019.08.744
Autor:
Arvind Sharma, Chirag C. Sheth, Apurva Vasavada, Rashmit Pandya, Dinesh O. Shah, Sameer Dani, Nirav Bhalani, Devang Desai, Pritesh Parekh
Publikováno v:
Journal of the American College of Cardiology. 74:B281
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cfc1131d46c8fc8e1bd7ca53a5ad1ee
https://doi.org/10.1016/j.jacc.2019.08.356
https://doi.org/10.1016/j.jacc.2019.08.356
Autor:
Pritesh Parekh, Arvind Sharma, Apurva Vasavada, Rutvik Trivedi, Nirav Bhalani, Kamal Sharma, Prathapkumar Natarajapillai, Sameer Dani, Chirag C. Sheth, Jayachandran Thejus
Publikováno v:
Journal of the American College of Cardiology. 69:S81-S82
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5f791708d6a6ef428115d1d55bb73ce
https://doi.org/10.1016/j.jacc.2017.03.195
https://doi.org/10.1016/j.jacc.2017.03.195